[1] LEE S Y, KO M K, LEE K N, et al. Application of mouse model for effective evaluation of foot-and-mouth disease vaccine[J]. Vaccine, 2016, 34(33):3731-3737.
[2] RYAN E, HORSINGTON J, DURAND S, et al. Foot-and-mouth disease virus infection in young lambs:pathogenesis and tissue tropism[J]. Vet Microbiol, 2008, 127(3-4):258-274.
[3] YAN D, TENG Z D, SUN S Q, et al. Foot-and-mouth disease virus-like particles as integrin-based drug delivery system achieve targeting anti-tumor efficacy[J]. Nanomedicine, 2016, 13(3):1061-1070.
[4] QUAN M, MURPHY C M, ZHANG Z, et al. Influence of exposure intensity on the efficiency and speed of transmission of foot-and-mouth disease[J]. J Comp Pathol, 2009, 140(4):225-237.
[5] GLOSTER J, JONES A, REDINGTON A, et al. Airborne spread of foot-and-mouth disease-model intercomparison[J]. Vet J, 2010, 183(3):278-286.
[6] ORSEL K, DE JONG M C M, BOUMA A, et al. Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs[J]. Vaccine, 2007, 25(34):6381-6391.
[7] CARRILLO C, LU Z, BORCA M V, et al. Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host[J]. J Virol, 2007, 81(20):11341-11351.
[8] WANG L, ZHENG J, LUO Y Z, et al. Construction of a genomewide RNAi mutant library in rice[J]. Plant Biotechnol J, 2013, 11(8):997-1005.
[9] ZHANG X X, ZHENG H X, XU M J, et al. Evaluation of a combinatorial RNAi lentivirus vector targeting foot-and-mouth disease virus in vitro and in vivo[J]. Mol Med Rep, 2015, 12(5):6672-6678.
[10] JIAO H W, DU L, HAO Y C, et al. Effective inhibition of mRNA accumulation and protein expression of H5N1 avian influenza virus NS1 gene in vitro by small interfering RNAs[J]. Folia Microbiol, 2013, 58(4):335-342.
[11] CHEN C F, SHENG J L. Transgenic shRNA pigs reduce susceptibility to foot and mouth disease virus infection[J]. New Biotechnol, 2016, 33 Suppl 1:S213.
[12] WANG H M, LIU X, WU J M, et al. Bovine fetal epithelium cells expressing shRNA targeting viral VP1 gene resisted against foot-and-mouth disease virus[J]. Virology, 2013, 439(2):115-121.
[13] WANG H M, WU J M, LIU X, et al. Identification of short hairpin RNA targeting foot-and-mouth disease virus with transgenic bovine fetal epithelium cells[J]. PLoS One, 2012, 7(8):e42356.
[14] LI W T, WANG K J, KANG S M, et al. Tongue epithelium cells from shRNA mediated transgenic goat show high resistance to foot and mouth disease virus[J]. Sci Rep, 2015, 5:17897.
[15] VAREDI M, MOATTARI A, AMIRGHOFRAN Z, et al. Effects of hypo-and hyperthyroid states on herpes simplex virus infectivity in the rat[J]. Endocr Res, 2014, 39(2):50-55.
[16] 宋一鸣, 杨洋, 张志东. 针对Asia-1型FMDV的qRT-PCR终点法中和试验的建立及初步研究[J]. 黑龙江畜牧兽医, 2016(19):42-47.
SONG Y M, YANG Y, ZHANG Z D. Establishment and preliminary study of a neutralization assay for Asia-1 type of FMDV using an end-point quantitative reverse transcription PCR[J]. Heilongjiang Animal Science and Veterinary Medicine, 2016(19):42-47. (in Chinese)
[17] DU J Z, GUO X B, GAO S D, et al. Induction of protection against foot-and-mouth disease virus in cell culture and transgenic suckling mice by miRNA targeting integrin αv receptor[J]. J Biotechnol, 2014, 187:154-161.
[18] UDDOWLA S, HOLLISTER J, PACHECO J M, et al. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals[J]. J Virol, 2012, 86(21):11675-11685.
[19] JOYAPPA D H, SASI S, ASHOK K C, et al. The plasmid constructs producing shRNA corresponding to the conserved 3D polymerase of foot and mouth disease virus protects guinea pigs against challenge virus[J]. Vet Res Commun, 2009, 33(3):263-271.
[20] KIM S M, LEE K N, LEE S J, et al. Multiple shRNAs driven by U6 and CMV promoter enhances efficiency of antiviral effects against foot-and-mouth disease virus[J]. Antiviral Res, 2010, 87(3):307-317.
[21] DE LOS SANTOS T, WU Q H, DE AVILA BOTTON S, et al. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus[J]. Virology, 2005, 335(2):222-231.
[22] LUO J H, DU J Z, GAO S D, et al. Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells[J]. Virol J, 2011, 8:428.
[23] SLIVA K, SCHNIERLE B S. Selective gene silencing by viral delivery of short hairpin RNA[J]. Virol J, 2010, 7:248.
[24] ZHOU S, MA Z J, LU T H, et al. Mouse transplant models for evaluating the oncogenic risk of a self-inactivating XSCID lentiviral vector[J]. PLoS One, 2013, 8(4):e62333.
[25] ZHANG S M, XIONG K, XIE Z R, et al. Stable silencing of β-lactoglobulin (BLG) gene by lentivirus-mediated RNAi in goat fetal fibroblasts[J]. Genet Mol Biol, 2012, 35(3):680-685.
[26] RYU B Y, ORWIG K E, OATLEY J M, et al. Efficient generation of transgenic rats through the male germline using lentiviral transduction and transplantation of spermatogonial stem cells[J]. J Androl, 2007, 28(2):353-360. |